Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 1;16(3):e0247522.
doi: 10.1371/journal.pone.0247522. eCollection 2021.

Self-management interventions for adults living with Chronic Obstructive Pulmonary Disease (COPD): The development of a Core Outcome Set for COMPAR-EU project

Estela Camus-García  1 , Ana Isabel González-González  1   2   3 , Monique Heijmans  4 , Ena Niño de Guzmán  5 , Claudia Valli  6   7 , Jessica Beltran  7 , Hector Pardo-Hernández  8 , Lyudmil Ninov  9 , Valentina Strammiello  9 , Kaisa Immonen  9 , Dimitris Mavridis  10 , Marta Ballester  1   3 , Rosa Suñol  1   3 , Carola Orrego  1   3
Affiliations

Self-management interventions for adults living with Chronic Obstructive Pulmonary Disease (COPD): The development of a Core Outcome Set for COMPAR-EU project

Estela Camus-García et al. PLoS One. .

Abstract

Background: A large body of evidence suggests that self-management interventions (SMIs) may improve outcomes in chronic obstructive pulmonary disease (COPD). However, accurate comparisons of the relative effectiveness of SMIs are challenging, partly due to heterogeneity of outcomes across trials and uncertainty about the importance of these outcomes for patients. We aimed to develop a core set of patient-relevant outcomes (COS) for SMIs trials to enhance comparability of interventions and ensure person-centred care.

Methods: We undertook an innovative approach consisting of four interlinked stages: i) Development of an initial catalogue of outcomes from previous EU-funded projects and/or published studies, ii) Scoping review of reviews on patients and caregivers' perspectives to identify outcomes of interest, iii) Two-round Delphi online survey with patients and patient representatives to rate the importance of outcomes, and iv) Face-to-face consensus workshop with patients, patient representatives, health professionals and researchers to develop the COS.

Results: From an initial list of 79 potential outcomes, 16 were included in the COS plus one supplementary outcome relevant to all participants. These were related to patient and caregiver knowledge/competence, self-efficacy, patient activation, self-monitoring, adherence, smoking cessation, COPD symptoms, physical activity, sleep quality, caregiver quality of life, activities of daily living, coping with the disease, participation and decision-making, emergency room visits/admissions and cost effectiveness.

Conclusion: The development of the COPD COS for the evaluation of SMIs will increase consistency in the measurement and reporting of outcomes across trials. It will also contribute to more personalized health care and more informed health decisions in clinical practice as patients' preferences regarding COPD outcomes are more systematically included.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Overall study design of core outcome set for COPD.
Fig 2
Fig 2. Consensus workshop decision manual.
Fig 3
Fig 3. Mapping of themes per COMPAR-EU taxonomy subdomain.
See this image and copyright information in PMC

References

    1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al.. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012. December;380(9859):2095–128. 10.1016/S0140-6736(12)61728-0 - DOI - PMC - PubMed
    1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al.. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012. December;380(9859):2163–96. 10.1016/S0140-6736(12)61729-2 - DOI - PMC - PubMed
    1. Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. Samet J, editor. PLoS Med. 2006. November 28;3(11):e442. 10.1371/journal.pmed.0030442 - DOI - PMC - PubMed
    1. Whitmore G, Aaron S, Gershon A, Gao Y, Yang J. Influence of country-level differences on COPD prevalence. Int J Chron Obstruct Pulmon Dis. 2016. September;Volume 11:2305–13. 10.2147/COPD.S113868 - DOI - PMC - PubMed
    1. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al.. An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2010. September;182(5):693–718. 10.1164/rccm.200811-1757ST - DOI - PubMed

Publication types

MeSH terms